{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:26:45Z","timestamp":1788470805262,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xkme.2026.101458","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:20:33Z","timestamp":1782573633000},"page":"101458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic Signatures of Inflammation in Chronic Kidney Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Teresa K.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya L.","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene P.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insa M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xkme.2026.101458_bib1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","article-title":"Targeting innate immunity-driven inflammation in CKD and cardiovascular disease","volume":"18","author":"Speer","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2026.101458_bib2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and progression of CKD: the CRIC Study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101458_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1681\/ASN.2019070723","article-title":"Plasma biomarkers of tubular injury and inflammation are associated with CKD progression in children","volume":"31","author":"Greenberg","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: a cohort study","volume":"79","author":"Guti\u00e9rrez","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"10.1016\/j.xkme.2026.101458_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/eurjpc\/zwad197","article-title":"Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study","volume":"30","author":"Jia","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.xkme.2026.101458_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2026.101458_bib8","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","article-title":"Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients","volume":"13","author":"Qureshi","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2020.11.014","article-title":"Biomarkers of immune activation and incident kidney failure with replacement therapy: findings from the African American Study of Kidney Disease and Hypertension","volume":"78","author":"Chen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/gfaa260","article-title":"Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality","volume":"36","author":"Chen","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101458_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1681\/ASN.2021060735","article-title":"Longitudinal TNFR1 and TNFR2 and kidney outcomes: results from AASK and VA NEPHRON-D","volume":"33","author":"Chen","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.ajkd.2023.05.017","article-title":"Associations of baseline and longitudinal serum uromodulin with kidney failure and mortality: results from the African American Study of Kidney Disease and Hypertension (AASK) trial","volume":"83","author":"Chen","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2215\/CJN.11700921","article-title":"Comparison of aptamer-based and antibody-based assays for protein quantification in chronic kidney disease","volume":"17","author":"Lopez-Silva","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2026.101458_bib14","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.2020111607","article-title":"Proteins associated with risk of kidney function decline in the general population","volume":"32","author":"Grams","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ng.377","article-title":"Multiple loci associated with indices of renal function and chronic kidney disease","volume":"41","author":"K\u00f6ttgen","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ekir.2020.12.025","article-title":"The associations of plasma biomarkers of inflammation with histopathologic lesions, kidney disease progression, and mortality-the Boston Kidney Biopsy Cohort study","volume":"6","author":"Srivastava","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"19","key":"10.1016\/j.xkme.2026.101458_bib17","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.xkme.2026.101458_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.xkme.2026.101458_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib20","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1681\/ASN.2017121260","article-title":"The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston Kidney Biopsy Cohort study","volume":"29","author":"Srivastava","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2215\/CJN.08600520","article-title":"NAT8 variants, N-acetylated amino acids, and progression of CKD","volume":"16","author":"Luo","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2026.101458_bib22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1681\/ASN.0000000000000403","article-title":"Serum and urine metabolites and kidney function","volume":"35","author":"Yeo","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101458_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100920","article-title":"Circulating protein and metabolite correlates of histologically confirmed diabetic kidney disease","volume":"6","author":"Lopez-Silva","year":"2024","journal-title":"Kidney Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101458_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2215\/CJN.14701121","article-title":"APOL1 kidney risk variants and proteomics","volume":"17","author":"Chen","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jalm\/jfac145","article-title":"Analytical and biological variability of a commercial modified aptamer assay in plasma samples of patients with chronic kidney disease","volume":"8","author":"Dubin","year":"2023","journal-title":"J Appl Lab Med"},{"issue":"19","key":"10.1016\/j.xkme.2026.101458_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.xkme.2026.101458_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100921","article-title":"Proteomics and incident kidney failure in individuals with CKD: the African American Study of Kidney Disease and Hypertension and the Boston Kidney Biopsy Cohort","volume":"6","author":"Chen","year":"2024","journal-title":"Kidney Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41591-023-02223-9","article-title":"The artificial sweetener erythritol and cardiovascular event risk","volume":"29","author":"Witkowski","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1681\/ASN.2020040487","article-title":"Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"32","author":"Schrauben","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","article-title":"Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study","volume":"73","author":"Amdur","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101458_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00011-020-01382-6","article-title":"The role of interferon-gamma in cardiovascular disease: an update","volume":"69","author":"Elyasi","year":"2020","journal-title":"Inflamm Res"},{"issue":"11","key":"10.1016\/j.xkme.2026.101458_bib33","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101063","article-title":"Interleukin-6 and cardiovascular events in healthy adults: MESA","volume":"3","author":"Khan","year":"2024","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.xkme.2026.101458_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2012.02.335","article-title":"Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"60","author":"Hiramoto","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101458_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacc.2018.04.053","article-title":"Association of IL-8 with infarct size and clinical outcomes in patients with STEMI","volume":"72","author":"Shetelig","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101458_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2215\/CJN.08660813","article-title":"The relationship between IL-10 levels and cardiovascular events in patients with CKD","volume":"9","author":"Yilmaz","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101458_bib38","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1681\/ASN.2016111162","article-title":"Serum uromodulin and mortality risk in patients undergoing coronary angiography","volume":"28","author":"Delgado","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ndt\/gfz008","article-title":"Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study","volume":"35","author":"Steubl","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2026.101458_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000489095","article-title":"Serum uromodulin: a biomarker of long-term kidney allograft failure","volume":"47","author":"Bostom","year":"2018","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101458_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100846","article-title":"Urine epidermal growth factor and kidney function decline in middle-aged adults","volume":"6","author":"Postalcioglu","year":"2024","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.xkme.2026.101458_bib42","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.ekir.2024.08.004","article-title":"Associations of urine epidermal growth factor with kidney and cardiovascular outcomes in individuals with CKD in SPRINT","volume":"9","author":"Postalcioglu","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/107999003322277829","article-title":"Synergistic transcriptional activation of indoleamine dioxygenase by IFN-\u03b3 and tumor necrosis factor-\u03b1","volume":"23","author":"Robinson","year":"2003","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"10.1016\/j.xkme.2026.101458_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/107999000312306","article-title":"Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently","volume":"20","author":"Currier","year":"2000","journal-title":"J Interferon Cytokine Res"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1006\/cyto.1999.0661","article-title":"Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells","volume":"12","author":"Babcock","year":"2000","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.xkme.2026.101458_bib46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib47","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/ndt\/gft217","article-title":"Metabolites associate with kidney function decline and incident chronic kidney disease in the general population","volume":"28","author":"Goek","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2026.101458_bib48","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2337\/dc23-1147","article-title":"Plasma tryptophan-kynurenine pathway metabolites and risk for progression to end-stage kidney disease in patients with type 2 diabetes","volume":"46","author":"Liu","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.jrn.2018.05.008","article-title":"The association of serum carotenoids, tocopherols, and ascorbic acid with rapid kidney function decline: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"29","author":"Hirahatake","year":"2019","journal-title":"J Ren Nutr"},{"issue":"21","key":"10.1016\/j.xkme.2026.101458_bib50","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2021.03.320","article-title":"Effects of diet and sodium reduction on cardiac injury, strain, and inflammation: the DASH-Sodium trial","volume":"77","author":"Juraschek","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101458_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026684","article-title":"Effects of the Dietary Approaches to Stop Hypertension diet on change in cardiac biomarkers over time: results from the DASH-Sodium trial","volume":"12","author":"Belanger","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.xkme.2026.101458_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028821","article-title":"Identification of protein biomarkers of the Dietary Approaches to Stop Hypertension diet in randomized feeding studies and validation in an observational study","volume":"12","author":"Kim","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.xkme.2026.101458_bib53","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/nu13041133","article-title":"Twelve-week Mediterranean diet intervention increases citrus bioflavonoid levels and reduces inflammation in people with type 2 diabetes mellitus","volume":"13","author":"Al-Aubaidy","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.xkme.2026.101458_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCULATIONAHA.107.710699","article-title":"Adherence to the mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study","volume":"117","author":"Dai","year":"2008","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.xkme.2026.101458_bib55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.xkme.2026.101458_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.ajkd.2016.05.019","article-title":"DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease","volume":"68","author":"Rebholz","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101458_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2020.04.019","article-title":"Adherence to healthy dietary patterns and risk of CKD progression and all-cause mortality: findings from the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"77","author":"Hu","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2026.101458_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14322","article-title":"Mediterranean diet adherence and risk of all-cause mortality in women","volume":"7","author":"Ahmad","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.xkme.2026.101458_bib59","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2215\/CJN.01780213","article-title":"Mediterranean diet, kidney function, and mortality in men with CKD","volume":"8","author":"Huang","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.xkme.2026.101458_bib60","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.xkme.2026.101458_bib61","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1515\/cclm-2017-1047","article-title":"IL8 and IL16 levels indicate serum and plasma quality","volume":"56","author":"Kofanova","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"10.1016\/j.xkme.2026.101458_bib62","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/dc16-0840","article-title":"Association of a biomarker of glucose peaks, 1,5-anhydroglucitol, with subclinical cardiovascular disease","volume":"39","author":"Liang","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.xkme.2026.101458_bib63","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/dom.13755","article-title":"Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial","volume":"21","author":"Selvin","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.xkme.2026.101458_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/db15-0607","article-title":"Association of 1,5-anhydroglucitol with cardiovascular disease and mortality","volume":"65","author":"Selvin","year":"2016","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.xkme.2026.101458_bib65","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/dme.13391","article-title":"Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial","volume":"34","author":"Juraschek","year":"2017","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101458_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003422","article-title":"Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes","volume":"11","author":"Trischitta","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.xkme.2026.101458_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015118","article-title":"Novel findings from a metabolomics study of left ventricular diastolic function: the Bogalusa Heart Study","volume":"9","author":"Razavi","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:07:30Z","timestamp":1788469650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526002207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2590059526002207"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101458","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic Signatures of Inflammation in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}],"article-number":"101458"}}